MentionFox
Home › funding signals › Foment Bio, Inc.
Form D · on the record

Foment Bio — $543K Form D filing, March 2025

Before you sell to, join or invest in Foment Bio, Inc.

MentionFox check on Foment Bio, Inc.: only 1 source on file so far (checked 4 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/foment-bio-inc-form-d-25000001

Check Foment Bio, Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about Foment Bio, Inc.?

Based on the record MentionFox holds for this company. No flag is not a clearance.

Foment Bio, Inc. filed a Form D with the Securities and Exchange Commission on 2025-03-21.

Foment Bio, Inc. filed a Form D notice of an exempt securities offering with the SEC on March 21, 2025. The filing reports $543K sold. Its industry group is Pharmaceuticals. It names Ben Chlebina (Executive Officer), Marc Penn (Director) (SEC Form D, March 21, 2025).

5 more Pharmaceuticals raises within 90 days of this one ↓

Is this your company?

Key facts

Run the free check on Foment Bio, Inc. →

Sell to companies like Foment Bio, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

Foment Bio, Inc.

New Form D on file · 2025-03-21 · the record

$543K
raise on the record
D
filing
12
investors in
TEXAS
based
Open the record →

What the record says

FilingForm D
Filed2025-03-21
Industry groupPharmaceuticals
Entity typeCorporation
Incorporated inDELAWARE
Year formed2023
BasedMONTGOMERY, TEXAS
CIK2062787
Accession0002062787-25-000001

Pitching, partnering or investing alongside them? See who really runs and owns Foment Bio, Inc.

Free to see. No signup.

Keep reading

More on the people and the money behind Foment Bio, Inc., from the filings we hold.

More raises like this

Pharmaceuticals raises filed within 90 days of this one, largest first.

What do you want to do with Foment Bio, Inc.?

Get the full cited report on Foment Bio, Inc.

What the filing shows about Foment Bio, Inc.

  • 12 investors had already put money in when it filed.
  • The filing names 2 people as officers, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News

A Full Report on Foment Bio, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

See a sample report

Who the filing names, and in what role

The filing gives Foment Bio, Inc.'s address as 148 Wick Willow Rd, Montgomery, TX 77356.

What the filing says

  • Offered: $1,000,000. Sold: $542,550. Left to sell: $457,450. (filing)
  • Investors: 12 had already invested, 5 of them not accredited. (filing)
  • Date of first sale: May 31, 2024. (filing)
  • Types of securities: Equity. (filing)
  • Item 16: the filing reports that none of the proceeds goes to executive officers, directors or promoters. (filing)

This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.

Order the Full Report on Foment Bio, Inc. See pricing

Is Foment Bio, Inc. a real, registered company?

Foment Bio, Inc. is a registered filer with the SEC (CIK 2062787) and has filed since 2025-03-21. 1 filing is on record, the latest on 2025-03-21.

A filing shows the company exists and what it reports about itself. It is not an audit or a rating.

Who runs Foment Bio, Inc.?

Foment Bio, Inc.'s Form D of 2025-03-21 names Ben Chlebina and Marc Penn as its officers, directors or promoters.

How much has Foment Bio, Inc. raised?

Its new offerings report $543K sold across 1 offering, as its own filings state.

Pharmaceuticals · by week

Trailing twelve months. 155 filings in Pharmaceuticals, totalled by week.

Want the whole picture on Foment Bio, Inc.?

What the filing shows about Foment Bio, Inc.

  • 12 investors had already put money in when it filed.
  • The filing names 2 people as officers, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News

A Full Report on Foment Bio, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Foment Bio, Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    1 cited source found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The full profile

Checking your access…

Is this you?

If you're behind Foment Bio, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.

Sourced from the filing index on sec.gov.

RSS

Tools for this story

Each opens in a new tab, filled in for Foment Bio, Inc.. With no account yet, you sign up free and land on the result.

More on Foment Bio, Inc.

Share this page

Is this your company?

Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.

Foment Bio, Inc.: Raised $543K, Form D filed 2025-03-21
Share on LinkedIn Share on X Download image

Cite this page

Permanent URL: https://mentionfox.com/funding/foment-bio-inc-form-d-25000001
Last updated 2026-11-04
Primary record: SEC filing 1 · SEC filing 2
Foment Bio raised $543K — SEC Form D filing, March 2025. MentionFox, 2026-11-04. https://mentionfox.com/funding/foment-bio-inc-form-d-25000001